These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 2692638

  • 1. The antidepressant effects of 5-HT uptake inhibitors.
    Aberg-Wistedt A.
    Br J Psychiatry Suppl; 1989 Dec; (8):32-40. PubMed ID: 2692638
    [Abstract] [Full Text] [Related]

  • 2. Therapeutic effects of serotonin uptake inhibitors in depression.
    Asberg M, Eriksson B, Mårtensson B, Träskman-Bendz L, Wägner A.
    J Clin Psychiatry; 1986 Apr; 47 Suppl():23-35. PubMed ID: 2937776
    [Abstract] [Full Text] [Related]

  • 3. A comparative examination of a role for serotonin in obsessive compulsive disorder, panic disorder, and anxiety.
    Murphy DL, Pigott TA.
    J Clin Psychiatry; 1990 Apr; 51 Suppl():53-8; discussion 59-60. PubMed ID: 2139026
    [Abstract] [Full Text] [Related]

  • 4. [Proserotoninergic agents and depression (author's transl)].
    Uzan A.
    Encephale; 1982 Apr; 8(2):273-89. PubMed ID: 6286277
    [Abstract] [Full Text] [Related]

  • 5. Clinical effects of serotonin reuptake inhibitors in the treatment of depressive illness.
    Burrows GD, McIntyre IM, Judd FK, Norman TR.
    J Clin Psychiatry; 1988 Aug; 49 Suppl():18-22. PubMed ID: 3045107
    [Abstract] [Full Text] [Related]

  • 6. Recent studies on selective serotonergic antidepressants: trazodone, fluoxetine, and fluvoxamine.
    Schatzberg AF, Dessain E, O'Neil P, Katz DL, Cole JO.
    J Clin Psychopharmacol; 1987 Dec; 7(6 Suppl):44S-49S. PubMed ID: 3123528
    [Abstract] [Full Text] [Related]

  • 7. Clinical overview of serotonin reuptake inhibitors.
    Rickels K, Schweizer E.
    J Clin Psychiatry; 1990 Dec; 51 Suppl B():9-12. PubMed ID: 2147922
    [Abstract] [Full Text] [Related]

  • 8. Serotonin receptor and reuptake sites: pharmacologic significance.
    Gonzalez-Heydrich J, Peroutka SJ.
    J Clin Psychiatry; 1990 Apr; 51 Suppl():5-12; discussion 13. PubMed ID: 2157701
    [Abstract] [Full Text] [Related]

  • 9. Controlled cross-over study of a 5-HT uptake inhibiting and an NA uptake inhibiting antidepressant.
    Aberg A.
    Acta Psychiatr Scand Suppl; 1981 Apr; 290():244-55. PubMed ID: 6452794
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics of the selective serotonin reuptake inhibitors.
    DeVane CL.
    J Clin Psychiatry; 1992 Feb; 53 Suppl():13-20. PubMed ID: 1531816
    [Abstract] [Full Text] [Related]

  • 11. Obsessive-compulsive disorder as a 5-HT subsystem-related behavioural disorder.
    Murphy DL, Zohar J, Benkelfat C, Pato MT, Pigott TA, Insel TR.
    Br J Psychiatry Suppl; 1989 Dec; (8):15-24. PubMed ID: 2692636
    [Abstract] [Full Text] [Related]

  • 12. Serotonergic dysfunction in depression.
    Meltzer H.
    Br J Psychiatry Suppl; 1989 Dec; (8):25-31. PubMed ID: 2692637
    [Abstract] [Full Text] [Related]

  • 13. Pharmacology of sertraline: a review.
    Heym J, Koe BK.
    J Clin Psychiatry; 1988 Aug; 49 Suppl():40-5. PubMed ID: 3045112
    [Abstract] [Full Text] [Related]

  • 14. Serotonin selectivity for obsessive compulsive and panic disorders.
    Montgomery SA, Bullock T, Fineberg N.
    J Psychiatry Neurosci; 1991 Jul; 16(2 Suppl 1):30-5. PubMed ID: 1931935
    [No Abstract] [Full Text] [Related]

  • 15. [Mechanism of action of antidepressants and therapeutic perspectives].
    Bourin M, David DJ, Jolliet P, Gardier A.
    Therapie; 2002 Jul; 57(4):385-96. PubMed ID: 12422559
    [Abstract] [Full Text] [Related]

  • 16. Effects of repeated treatment with fluoxetine and citalopram, 5-HT uptake inhibitors, on 5-HT1A and 5-HT2 receptors in the rat brain.
    Klimek V, Zak-Knapik J, Mackowiak M.
    J Psychiatry Neurosci; 1994 Jan; 19(1):63-7. PubMed ID: 8148368
    [Abstract] [Full Text] [Related]

  • 17. Prolonged treatment with the specific 5-HT-uptake inhibitor citalopram: effect on dopaminergic and serotonergic functions.
    Arnt J, Hyttel J, Overø KF.
    Pol J Pharmacol Pharm; 1984 Jan; 36(2-3):221-30. PubMed ID: 6591152
    [Abstract] [Full Text] [Related]

  • 18. The clinical utility of pharmacological agents that act at serotonin receptors.
    Peroutka SJ, Sleight AJ, McCarthy BG, Pierce PA, Schmidt AW, Hekmatpanah CR.
    J Neuropsychiatry Clin Neurosci; 1989 Jan; 1(3):253-62. PubMed ID: 2562495
    [Abstract] [Full Text] [Related]

  • 19. [Central serotonin receptors. Principal fundamental and functional aspects. Therapeutic applications].
    Moulignier A.
    Rev Neurol (Paris); 1994 Jan; 150(1):3-15. PubMed ID: 7801037
    [Abstract] [Full Text] [Related]

  • 20. [Central serotonin receptors and chronic treatment with selective serotonin reuptake inhibitors in the rat: comparative effects of fluoxetine and paroxetine].
    Le Poul E, Lima L, Laporte AM, Even C, Doucet E, Fattaccini CM, Laaris N, Hamon M, Lanfumey L.
    Encephale; 1995 Jan; 21(2):123-32. PubMed ID: 7781583
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.